Improvements to the technology infrastructure for researching and developing new biopharmaceuticals would be expected to save the industry hundreds of millions of dollars annually, according to a new economic study sponsored by NIST.
Obese people are six times as likely to develop gullet (oesophageal) cancer as people of ‘healthy’ weight, shows research published ahead of print in the journal Gut.
The International Diabetes Federation (IDF) has published new guidelines on the contribution and impact of post-meal glucose in diabetes disease management at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD) on September_19, 2007. The IDF recognises the growing evidence that post-meal glucose is a key contributor to overall glycaemic control – particularly with respect to HbA1C levels, and that reducing post-meal glucose has a significant impact on the risk of developing diabetic complications.
Researchers are now one step closer to improved treatment of Type 2 diabetes following significant findings made by scientists at the Garvan Institute of Medical Research.
Even relatively low doses of resveratrol—a chemical found in the skins of red grapes and in red wine—can improve the sensitivity of mice to the hormone insulin, according to a report in the October issue of Cell Metabolism, a Cell Press publication.
A glitch in the production and folding of molecules deep within the insulin-producing cells of the pancreas may be responsible for the death of those cells and the onset of diabetes, new animal research suggests.
A new Joslin-led study has shown that leptin, a hormone known mainly for regulating appetite control and energy metabolism, plays a major role in islet cell growth and insulin secretion. This finding opens up new avenues for studying leptin and its role in islet cell biology, which may lead to new treatments for diabetes.
Amylin Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the SymlinPen(TM) 120 and the SymlinPen(TM) 60 pen-injector devices for administering SYMLIN(R) (pramlintide acetate) injection.
Researchers in Brazil have found that treating patients who suffer from obstructive sleep apnea (OSA) with continuous positive airway pressure (CPAP) dramatically reduces early indications of atherosclerosis in just months, linking OSA directly to the hardening or narrowing of the arteries.
Dietary intake of omega-3 fatty acids was associated with a reduced risk of pancreatic islet autoimmunity and thereby reducing the risk to develop diabetes in children, revealed by researchers in a recent study published in JAMA.